Micronbrane Medical Co Ltd

Devin Blood Fractionation membrane, Pathogen Real-Time Identification by Sequencing (PaRTI-Seq) and Bioinformatic Services

Mitek Lab Co., Ltd.

IVD & Life Science Material:
● Latex beads - IMMUTEX™
● Magnetic beads - Magnosphere™
● Blocking reagent - Blockmaster™
● Nanoparticle - BioReady
● Antibody purification - Amsphere A3
● Clinical specimen - ACCESS
Cell Therapy Material & Device:
● Human AB Serum - ACCESS
● Bioreactor - ABLE
● On-chip Sort – On-chip

Molsentech

Ultra-high sensitivity biomedical detection platform-SENEDIA
Founded in 2014, Molsentech is dedicated to developing a biomedical platform that facilitates the non-invasive and real-time detection of minimum pathogens for patients.
Our core team is composed of professionals from the Quantum Electronic Laboratory at Academia Sinica with exclusive expertise in semiconductor chip design/fabrication, probe molecules modification and automation bio-sensor system integration. In addition, our researches were published by SCI journal and earned relevant patents. With widely-recognized performance. Molsentech was honored to win the 13th National Innovation Award in 2016.
Going forward, Molsentech will leverage this top-notch platform to provide high sensitive, accurate and user-friendly products in the biomedical detection market worldwide.

National Health Research Institutes

The National Health Research Institutes (NHRI) is a non-profit foundation established by the government with its organization charter created by an Act of Congress (Legislative Yuan) and signed in 1995 by President Teng-hui Lee. Being an autonomous research organization under the supervision of the Department of Health, Executive Yuan, the NHRI is dedicated to the enhancement of medical research and the improvement of health care in this country.

Scientists at the NHRI conduct mission-oriented medical research and investigate many aspects of the basic biomedical sciences, as well as specific diseases. These range from the common problems such as aging, cancer, infectious diseases, mental disorders, occupational diseases, to health policy. It is our hope that the knowledge, experience, and facilities at the NHRI will become important resources to the whole nation in understanding, preventing, and curing diseases. There are several collaborative research projects between the NHRI and medical centers and hospitals. It is anticipated that both public and private sector efforts of the NHRI will help achieve excellence in medical research in Taiwan.

For more information, please visit https://www.nhri.edu.tw/eng/

Pishon Biomedical Co., Ltd

Pishon Biomedical Co., Ltd has advanced 3D cell culture technology, which applies this unique patented technology to screening of clinical drugs, the development of new drugs, and the establishment of tumor models and biological databases. In 2016, OncoTreat ® drug screening platform to culture patient derived organoids (PDOs) models of tumor cells from patients through Cellusponge. Based on this model, the sensitivity test of chemotherapy drugs is carried out, and a number of cancer drugs are tested in a short period of time, which provides reference data for clinical drug use. Compared with patient derived xenograft (PDX), PDO was able to use a small number of tests to achieve a culture success rate of more than 95%. Drug sensitivity testing can be completed in as few as 2 weeks, and high-throughput drug screening can significantly reduce patient waiting times and costs, effectively providing clinical treatment options. Enable potential tumor patients to be detected early and provide evaluation of treatment efficacy and post-treatment monitoring and tracking.

Pishon Biomedical expects the best care for patients.

PODAK CO.,LTD.

Fully Automatic Transfer Machine
We succeeded in miniaturizing and reducing the cost of fully automatic trransfer machine. The machine has been a better efficiency and practically applicable for clinical purposes in addition to laboratories and pharmaceutical applications. This was achieved with the help of noncontaminable camera and a 6-axis robot arm with 3 fingers.

Prisma Biotech

1.) Single cell Sequencing
2.) Oncology
3.) Microbiome

provitaebio

Pro_Screen

PURIBLOOD MEDICAL CO, LTD

PuriBlood is committed to improving the blood filtration process with innovative technology of ‘Zwitterionic-bias Surface Coating Technology (ZISC technology)’. Through ZISC technology, our products provide better and stable filtration performance, which can remove more than 99.99% of white blood cells and reduce filtration time. Our product includes:
(A) "Puriblood" Leukocyte reduction filter for red blood cells
(B) "Devin" Microbio enrichment filter
(C) "MiniPuri" Syringe filter for leuko-reduction of PRP

PuriBlood, in conjunction with RDCMT, holds over 36+ patents supporting our core membrane technology. Our partners include known international group and exceptional clinician. We aim for bringing the world a safer way in transfusion and cell therapy.

QIAGEN Taiwan

Sample technologies isolate, stabilize and prepare genomic materials from raw materials such as blood or tissue, soil or water, or forensic “trace” evidence.

Assay technologies make relevant molecules visible and ready for analysis, whether to identify a single pathogen or genetic variation – or to paint an in-depth genomic profile.

Automation systems implement efficient, end-to-end workflows for analysis by polymerase chain reaction (PCR), next-generation sequencing (NGS) and other techniques.

Bioinformatics deliver the value from these workflows with user-friendly software and cloud-based resources to interpret data and report actionable insights from vast amounts of complex biological data.